{"id":63839,"date":"2026-04-23T22:15:01","date_gmt":"2026-04-23T14:15:01","guid":{"rendered":"https:\/\/flcube.com\/?p=63839"},"modified":"2026-04-23T22:15:02","modified_gmt":"2026-04-23T14:15:02","slug":"abbvie-announces-1-4-billion-advanced-manufacturing-campus-in-north-carolina-to-support-immunology-neuroscience-and-oncology-portfolio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=63839","title":{"rendered":"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio"},"content":{"rendered":"\n<p><strong>AbbVie (<a href=\"https:\/\/www.google.com\/finance\/quote\/ABBV:NYSE\">NYSE: ABBV<\/a>)<\/strong> has announced plans to invest <strong>$1.4 billion<\/strong> to construct a state-of-the-art <strong>pharmaceutical manufacturing campus<\/strong> spanning <strong>185 acres<\/strong> in <strong>Durham, North Carolina<\/strong>. The facility will integrate <strong>advanced manufacturing technologies<\/strong> with <strong>artificial intelligence (AI)<\/strong> to support production of AbbVie&#8217;s key medicines in <strong>immunology, neuroscience, and oncology<\/strong>. This project represents a significant component of the company&#8217;s broader <strong>$100 billion commitment<\/strong> to U.S. research and development and capital investments, including manufacturing, over the next decade.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investment-summary\">Investment Summary<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>AbbVie (NYSE: ABBV)<\/td><\/tr><tr><td><strong>Total Investment<\/strong><\/td><td>$1.4 billion<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Durham, North Carolina<\/td><\/tr><tr><td><strong>Campus Size<\/strong><\/td><td>185 acres<\/td><\/tr><tr><td><strong>Strategic Focus<\/strong><\/td><td>Immunology, neuroscience, and oncology medicines<\/td><\/tr><tr><td><strong>Technology Integration<\/strong><\/td><td>Advanced manufacturing + artificial intelligence (AI)<\/td><\/tr><tr><td><strong>Broader Commitment<\/strong><\/td><td>Part of $100 billion U.S. R&amp;D and capital investment pledge (2026\u20132036)<\/td><\/tr><tr><td><strong>Employment Impact<\/strong><\/td><td>Expected to create 800+ high-skilled jobs over 5 years<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-campus-development-phases\">Campus Development Phases<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Initial Phase Infrastructure:<\/strong><\/li>\n\n\n\n<li><strong>Small-volume parenteral (SVP) drug manufacturing facility<\/strong> for specialized biologics and injectables<\/li>\n\n\n\n<li><strong>Next-generation laboratories<\/strong> equipped with AI-driven analytical and process development capabilities<\/li>\n\n\n\n<li><strong>Automated warehouses<\/strong> with advanced logistics and cold chain management systems<\/li>\n\n\n\n<li><strong>Administrative offices<\/strong> supporting operational and technical teams<\/li>\n\n\n\n<li><strong>Employee wellness facilities<\/strong> including fitness centers, dining, and collaborative workspaces<\/li>\n\n\n\n<li><strong>Future Expansion Capacity:<\/strong> Dedicated space reserved to accommodate AbbVie&#8217;s growing product pipeline and pipeline candidates advancing through clinical development<\/li>\n\n\n\n<li><strong>Sustainability Features:<\/strong> LEED-certified design with renewable energy integration and water conservation systems<\/li>\n\n\n\n<li><strong>Digital Backbone:<\/strong> Enterprise-wide IoT connectivity and real-time monitoring systems for quality assurance and operational excellence<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-impact-assessment\">Strategic Impact Assessment<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Aspect<\/th><th>Analysis<\/th><\/tr><\/thead><tbody><tr><td><strong>Portfolio Alignment<\/strong><\/td><td>Directly supports AbbVie&#8217;s blockbuster immunology franchise (Humira, Skyrizi, Rinvoq) and growing neuroscience\/oncology pipelines<\/td><\/tr><tr><td><strong>Manufacturing Innovation<\/strong><\/td><td>AI integration enables predictive maintenance, real-time quality control, and adaptive manufacturing processes<\/td><\/tr><tr><td><strong>Supply Chain Resilience<\/strong><\/td><td>Enhances U.S.-based manufacturing capacity for critical medicines, reducing dependency on international supply chains<\/td><\/tr><tr><td><strong>Economic Impact<\/strong><\/td><td>Significant boost to North Carolina&#8217;s Research Triangle life sciences ecosystem and local economy<\/td><\/tr><tr><td><strong>Competitive Positioning<\/strong><\/td><td>Reinforces AbbVie&#8217;s commitment to U.S. manufacturing leadership amid increasing regulatory emphasis on domestic pharmaceutical production<\/td><\/tr><tr><td><strong>Timeline<\/strong><\/td><td>Construction expected to begin Q3 2026, with initial operations commencing by late 2028<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<p>This $1.4 billion investment underscores AbbVie&#8217;s long-term commitment to maintaining manufacturing excellence while positioning the company at the forefront of pharmaceutical innovation. The integration of <strong>artificial intelligence with advanced manufacturing<\/strong> represents a paradigm shift from traditional pharmaceutical production to intelligent, data-driven operations that can adapt in real-time to optimize quality, efficiency, and flexibility.<\/p>\n\n\n\n<p>The <strong>Durham location<\/strong> strategically leverages North Carolina&#8217;s established life sciences corridor, providing access to world-class talent from nearby universities and research institutions, as well as proximity to existing biopharmaceutical infrastructure in the Research Triangle Park area.<\/p>\n\n\n\n<p>As part of AbbVie&#8217;s <strong>$100 billion decade-long commitment<\/strong>, this campus represents a cornerstone investment that will support the company&#8217;s transition beyond its Humira franchise into next-generation therapies across multiple therapeutic areas. The focus on <strong>small-volume parenteral manufacturing<\/strong> is particularly strategic, given the increasing complexity and specialization of modern biologic and cell\/gene therapies.<\/p>\n\n\n\n<p>The inclusion of <strong>dedicated expansion space<\/strong> demonstrates forward-thinking planning that anticipates AbbVie&#8217;s robust pipeline advancement, including late-stage candidates in immunology (e.g., ABBV-594 for lupus), neuroscience (ABBV-951 for Parkinson&#8217;s disease), and oncology (telisotuzumab vedotin and other ADC platforms).<\/p>\n\n\n\n<p>This announcement also aligns with broader U.S. government initiatives to strengthen domestic pharmaceutical manufacturing capabilities and reduce reliance on foreign supply chains for critical medicines, potentially positioning AbbVie favorably for future public-private partnerships and incentives.<\/p>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding capital investments, strategic initiatives, and business development. Actual results may differ due to regulatory approvals, construction timelines, market conditions, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[234,853],"class_list":["post-63839","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-abbvie","tag-nyse-abbv"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical manufacturing campus spanning 185 acres in Durham, North Carolina. The facility will integrate advanced manufacturing technologies with artificial intelligence (AI) to support production of AbbVie&#039;s key medicines in immunology, neuroscience, and oncology. This project represents a significant component of the company&#039;s broader $100 billion commitment to U.S. research and development and capital investments, including manufacturing, over the next decade.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=63839\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio\" \/>\n<meta property=\"og:description\" content=\"AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical manufacturing campus spanning 185 acres in Durham, North Carolina. The facility will integrate advanced manufacturing technologies with artificial intelligence (AI) to support production of AbbVie&#039;s key medicines in immunology, neuroscience, and oncology. This project represents a significant component of the company&#039;s broader $100 billion commitment to U.S. research and development and capital investments, including manufacturing, over the next decade.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=63839\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-23T14:15:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T14:15:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63839#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63839\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio\",\"datePublished\":\"2026-04-23T14:15:01+00:00\",\"dateModified\":\"2026-04-23T14:15:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63839\"},\"wordCount\":603,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AbbVie\",\"NYSE: ABBV\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63839#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63839\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=63839\",\"name\":\"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-23T14:15:01+00:00\",\"dateModified\":\"2026-04-23T14:15:02+00:00\",\"description\":\"AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical manufacturing campus spanning 185 acres in Durham, North Carolina. The facility will integrate advanced manufacturing technologies with artificial intelligence (AI) to support production of AbbVie's key medicines in immunology, neuroscience, and oncology. This project represents a significant component of the company's broader $100 billion commitment to U.S. research and development and capital investments, including manufacturing, over the next decade.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63839#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63839\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63839#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio - Insight, China&#039;s Pharmaceutical Industry","description":"AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical manufacturing campus spanning 185 acres in Durham, North Carolina. The facility will integrate advanced manufacturing technologies with artificial intelligence (AI) to support production of AbbVie's key medicines in immunology, neuroscience, and oncology. This project represents a significant component of the company's broader $100 billion commitment to U.S. research and development and capital investments, including manufacturing, over the next decade.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=63839","og_locale":"en_US","og_type":"article","og_title":"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio","og_description":"AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical manufacturing campus spanning 185 acres in Durham, North Carolina. The facility will integrate advanced manufacturing technologies with artificial intelligence (AI) to support production of AbbVie's key medicines in immunology, neuroscience, and oncology. This project represents a significant component of the company's broader $100 billion commitment to U.S. research and development and capital investments, including manufacturing, over the next decade.","og_url":"https:\/\/flcube.com\/?p=63839","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-23T14:15:01+00:00","article_modified_time":"2026-04-23T14:15:02+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=63839#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=63839"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio","datePublished":"2026-04-23T14:15:01+00:00","dateModified":"2026-04-23T14:15:02+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=63839"},"wordCount":603,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AbbVie","NYSE: ABBV"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=63839#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=63839","url":"https:\/\/flcube.com\/?p=63839","name":"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-23T14:15:01+00:00","dateModified":"2026-04-23T14:15:02+00:00","description":"AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical manufacturing campus spanning 185 acres in Durham, North Carolina. The facility will integrate advanced manufacturing technologies with artificial intelligence (AI) to support production of AbbVie's key medicines in immunology, neuroscience, and oncology. This project represents a significant component of the company's broader $100 billion commitment to U.S. research and development and capital investments, including manufacturing, over the next decade.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=63839#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=63839"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=63839#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63839"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63839\/revisions"}],"predecessor-version":[{"id":63840,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63839\/revisions\/63840"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}